Fennec Pharmaceuticals Statistics
NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
10.36+0.01 (+0.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Fennec Pharmaceuticals by the numbers
Fennec Pharmaceuticals has a market capitalization of $363.3 million based on 35.07M shares outstanding. With trailing EPS of $-0.12, Fennec Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.1% below its 50-day average and 15.6% above its 200-day average.
Average daily trading volume is 193.70K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FENC valuation vs. peer median
| Metric | FENC | Peer median | Difference |
|---|---|---|---|
| Market cap | $363.30M | $342.05M | +6% |
| Avg. volume | 193.70K | 1.93M | -90% |
Peer median across 8 companies: CCCC, KYTX, ARTV, AGEN, OCGN, CABA, SCTX, ZURA.
Valuation
- Market cap
- $363.30M
- Forward P/E
- 10.93
- EPS (TTM)
- $-0.12
- Shares outstanding
- 35.07M
Price and trading
- Previous close
- 10.35
- Open
- 10.21
- Day range
- 10.08 – 10.65
- 52-week range
- 5.65 – 13.25
- 52-week change
- +9.28%
- Beta
- —
- Volume
- 130.78K
- Average volume
- 193.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 363.30M
- Forward Pe
- 10.93
- Eps
- -0.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.25
- Week52 Low
- 5.65
- Avg Volume
- 193.70K
- Shares Outstanding
- 35.07M
- Ma50
- 11.15
- Ma200
- 8.96
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -21.81%
- Pct From52w Low
- 83.36%